AI Pharma Startup METiS Raises $150 Million. IPO in Sight?
Company has conducted five financing rounds since its establishment in January 2020 Key takeaways: METiS Pharmaceuticals has completed five funding rounds since its establishment in January 2020, including the latest…
Recent Articles
RELATED ARTICLES
-
Earnings blow for CSPC Pharma as the state drives a hard bargain
1093.HK
-
Xuanzhu Biopharm set for spin-off in Hong Kong IPO
0460.HK
- Cloudbreak Pharma sets sights on Hong Kong IPO after license deal
- Innogen Pharma jostles for a slice of the weight-loss market
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
- Cancer drug maker Genfleet joins Hong Kong IPO influx
-
Hengrui Pharma accelerates bid for global brand status
600276.SHG
Discover hidden China stock gems in our weekly newsletter